Fezolamine

CAS No. 80410-36-2

Fezolamine( —— )

Catalog No. M36171 CAS No. 80410-36-2

Fezolamine is a novel orally available non-tricyclic compound with antidepressant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 247 In Stock
10MG 371 In Stock
25MG 620 In Stock
50MG 863 In Stock
100MG 1172 In Stock
200MG Get Quote In Stock
500MG 2353 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fezolamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Fezolamine is a novel orally available non-tricyclic compound with antidepressant activity.
  • Description
    Fezolamine is a novel orally available non-tricyclic compound with antidepressant activity. It is three to two times more selective in blocking synaptosomal uptake of [3H]norepinephrine than uptake of [4H]3-hydroxytryptamine or [3H]dopamine in vitro. It blocked the inhibitory effects of rifampicin and tetraphenyl in classical behavioral tests using monoamine-depleted animals.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    Norepinephrine
  • Recptor
    Norepinephrine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    80410-36-2
  • Formula Weight
    305.42
  • Molecular Formula
    C20H23N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CCN(C)C)N1C=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Cianopramine

    Cianopramine (Ro 112465) is a selective 5-hydroxytryptamine uptake inhibitor and a tricyclic antidepressant used in the study of neurological disorders.

  • Levomilnacipran

    Levomilnacipran is a selective serotonin and norepinephrine reuptake inhibitor.

  • Milnacipran hydrochl...

    Milnacipran hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia.